newsfilter
← Latest News
Business Wire·

KaliVir Immunotherapeutics Appoints Schond Greenway as Chief Financial Officer

KaliVir Immunotherapeutics, Inc., a biotech company developing cutting-edge, multi-mechanistic oncolytic viral immunotherapy programs, today announces the appointment of Schond Greenway as Chief Financial Officer (CFO).